You have accessJournal of UrologyTransplantation & Vascular Surgery: Renal Transplantation & Vascular Surgery II1 Apr 2017MP30-18 RACIAL DISPARITIES IN RENAL TRANSPLANTATION Benjamin Abelson, Colette Harris, Jamie Mitchell, Songhua Lin, and Charles Modlin Benjamin AbelsonBenjamin Abelson More articles by this author , Colette HarrisColette Harris More articles by this author , Jamie MitchellJamie Mitchell More articles by this author , Songhua LinSonghua Lin More articles by this author , and Charles ModlinCharles Modlin More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2017.02.951AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES African American (AA) patients have increased rates of end-stage renal disease compared to Caucasian American (CA) patients, and despite making up 13% of the American population, AAs comprise over 30% of the kidney transplantation list. This study seeks to better define our institutional experience in renal transplantation for AA patients in order to identify methods to reduce previously published racial disparities in access to and outcomes after renal transplantation. METHODS We retrospectively reviewed the most recent fifteen years of kidney transplants at our institution. Clinical and demographic characteristics were collected from the electronic medical record. Kaplan Meier curves were generated for patient and graft survival, stratified by race and by living versus deceased donor transplantation. RESULTS A total of 1840 kidney transplants were performed at our institution from 2000-2016, including 1393 CA patients and 447 AA patients. 944 of the transplants were from living donors (LD) and 846 were from deceased donors (DD). Among the 1393 transplants for CAs, 818 (59%) were from LDs, whereas among the 447 AA transplants, only 126 were LD transplants (28%, p<0.001). There was no difference in patient survival between AA and CA recipients of deceased donor recipients or living donor recipients. Graft survival was longer in CA recipients of DD transplants (mean number, p<0.0001) but there was no significance in the graft survival difference between AA and CA recipients of LD transplants (Figure 1). CONCLUSIONS Living donation confers a graft and overall survival advantage compared to DD, and this is true among both AA and CA patients. At our institution there is no significant difference in graft or patient survival between AA and CA patients after living donation, though after deceased donation CAs have improved graft and patient survival. Furthermore, there is a striking difference in utilization of LD transplant between AA and CA patients. This demonstrates the need for further study of why AA patients are severely underrepresented in LD transplants, and improved education and communication regarding living donation among the AA community. © 2017FiguresReferencesRelatedDetails Volume 197Issue 4SApril 2017Page: e396-e397 Advertisement Copyright & Permissions© 2017MetricsAuthor Information Benjamin Abelson More articles by this author Colette Harris More articles by this author Jamie Mitchell More articles by this author Songhua Lin More articles by this author Charles Modlin More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...